Aphex Pharma Solutions

Conference Agenda 2026

8:00 am

Registration and Networking

8:45 am

Welcome and Opening Remarks

Ahsan Syed Ali

Managing Director

Aphex Pharma Solutions

Welcome to PDC 2026

9:00 am

Keynote Presentation

Dr. Rebecca Tunstall

Chief Operating Officer

Prescient Therapeutics

Building the Development Engine: From Bench to Phase 2 and Beyond - Bringing a First-in-Class Therapy to Patients

9:30 am

Company Story and Product Development Updates

Dr. Tracey Brown

Chief Executive Officer

GAIASO Theranostics

GAIASO Technology Development Approach and Plans

9:50 am

Company Story And Product Development Update

Dr. Eliana Mariño

CEO & Founder

ImmunoBiota Therapeutics Pty Ltd

Company Story And Product Development Update

10:00 am

Company Story and Product Development Updates

Leopoldt de Bruin

CEO and Managing Director

ESN Cleer

Product Development Update

10:10 am

Company Story and Product Development Updates

Dr. Sarika Namjoshi

Chief Operating Officer

Tissue Repair Ltd

Product Development Update

10:20 am

Unlocking Non-Dilutive Capital: Funding Strategies for Growth

Stuart Haines

Founder and CEO

Haines Consulting Group

Unlocking Non-Dilutive Capital: Funding Strategies for Growth

10:30 am

Morning Tea and Networking Break

11:00 am

Pre-Clinical & Clinical Development

Room 1 - Octagonal

Greg Plunkett

CEO and Managing Director

Accelagen

Formulation & Manufacturing Development

Room 2 - Estate Vineyard

Dr. Michael Andrews Luke

CEO & Managing Director

Formulytica

11:30 am

Pre-Clinical & Clinical Development

Room 1 - Octagonal

Dr. Jason Wang

Site Head

Resolian

Formulation & Manufacturing Development

Room 2 - Estate Vineyard

Justine Mann

Chief Executive Officer

Pure Solutions Australia Pty Ltd

Trial Success Through Robust Sterile Drug Product Manufacturing

12:00 pm

Pre-Clinical & Clinical Development

Room 1 - Octagonal

Matthew Bugg

Global Quality Director

MaHPharma Pty Ltd

Formulation & Manufacturing Development

Room 2 - Estate Vineyard

Ahsan Syed Ali

Managing Director

Aphex Pharma Solutions

12:30 pm

Lunch and Networking Break

1:30 pm

Pre-Clinical & Clinical Development

Room 1 - Octagonal

Coming Soon

IND Enabling Tox Program

Formulation & Manufacturing Development

Room 2 - Estate Vineyard

Dr. Maiada Sadek

CMC Consultant

Aphex Pharma Solutions

2:00 pm

Pre-Clinical & Clinical Development

Room 1 - Octagonal

Coming Soon

Nonclinical Development Strategies for Global Submissions

Formulation & Manufacturing Development

Room 2 - Estate Vineyard

Adriana Terreros

Quality Consultant

Aphex Pharma Solutions

2:30 pm

Pre-Clinical & Clinical Development

Room 1 - Octagonal

Coming Soon

Clinical Trial Opportunities in APAC Region

Formulation & Manufacturing Development

Room 2 - Estate Vineyard

Ana Benatti

Head of Quality and Regulatory Affairs

QBiotics

3:00 pm

Afternoon Tea and Networking Break

3:30 pm

Pre-Clinical & Clinical Development

Room 1 - Octagonal

Coming Soon

Formulation & Manufacturing Development

Room 2 - Estate Vineyard

Coming Soon

4:00 pm

Plenary Session

Ahsan Syed Ali

Managing Director

Aphex Pharma Solutions

Plenary Session

4:30 pm

Panel Discussion, Q&A and Closing Comments

5:00 pm

Networking Session (RSVP Only)

Want to Present at PDC 2026?

We're looking for industry experts to share their insights and experiences. Contact us to submit your presentation proposal.

Submit Proposal Back to PDC 2026

For updates on the full agenda and speaker lineup, please contact us or check back soon.